A multi-centre study of zomepirac in painful conditions: an analysis of clinical data for 15,484 patients
- PMID:6221886
- DOI: 10.1185/03007998309111743
A multi-centre study of zomepirac in painful conditions: an analysis of clinical data for 15,484 patients
Abstract
An open, multi-centre study was carried out in patients with various moderate to severe painful conditions to assess the effectiveness of zomepirac in relieving pain. Patients were treated with 300 mg to 600 mg zomepirac daily for 7 days. Data from 15,484 patients have been analyzed. Most of the patients (75%) were already being treated with an analgesic on entry and more than half of them had been prescribed this by their doctor. Almost half, however, had still been in pain for more than 4 weeks before receiving zomepirac. An analysis of pain severity assessments showed a reduction from an initial score of 2.4 to 1.3 (on a 4-point rating scale). Global responses were recorded and 71.7% of the patients were considered to have improved according to the opinion of both doctors and patients, with the best response (84.1%) being observed in those with acute painful states such as sprains, strains and fractures and with pain of short duration. Pain frequently disrupts sleep, and 46.2% of patients reported their sleep as 'bad' or 'very bad' on entry to the study. After treatment, this figure was reduced to 15.1%. The side-effects reported, which were mainly gastro-intestinal, were mild in general and led to withdrawal of only 7.2% of the patients before completion of treatment.
Similar articles
- Long-term therapy for the pain of osteoarthritis: a comparison of zomepirac sodium and aspirin.Honig S.Honig S.J Clin Pharmacol. 1983 Nov-Dec;23(11-12):494-504. doi: 10.1002/j.1552-4604.1983.tb01796.x.J Clin Pharmacol. 1983.PMID:6363464Clinical Trial.
- A double-blind study comparing single dose of intramuscularly injected zomepirac to meperidine in the treatment of postoperative pain.Baird WM, Turek MD, Minn FL, Brown RH.Baird WM, et al.Pharmacotherapy. 1986 Sep-Oct;6(5):219-27. doi: 10.1002/j.1875-9114.1986.tb03480.x.Pharmacotherapy. 1986.PMID:3540872Clinical Trial.
- [Evaluation of the analgesic activity of zomepirac sodium on sciatica and lower back pain].Pipino F, Patella V, Moretti B, Pesce V.Pipino F, et al.Boll Chim Farm. 1984 Jan;123(1):1S-5S.Boll Chim Farm. 1984.PMID:6232934Clinical Trial.Italian.No abstract available.
- Evaluation of zomepirac sodium.McEvoy GK.McEvoy GK.Am J Hosp Pharm. 1981 Sep;38(9):1293-301.Am J Hosp Pharm. 1981.PMID:7025615Review.
- Zomepirac: a review of its pharmacological properties and analgesic efficacy.Morley PA, Brogden RN, Carmine AA, Heel RC, Speight TM, Avery GS.Morley PA, et al.Drugs. 1982 Apr;23(4):250-75. doi: 10.2165/00003495-198223040-00002.Drugs. 1982.PMID:7044754Review.
Cited by
- Selected β2-, β3- and β2,3-Amino Acid Heterocyclic Derivatives and Their Biological Perspective.Bąchor U, Mączyński M.Bąchor U, et al.Molecules. 2021 Jan 15;26(2):438. doi: 10.3390/molecules26020438.Molecules. 2021.PMID:33467741Free PMC article.Review.
Publication types
MeSH terms
Substances
Related information
LinkOut - more resources
Full Text Sources
Medical
Research Materials